Navigation Links
Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer
Date:9/6/2007

oma as the most common form of lung cancer among women in the 1975-79 period and among men during the 1980-84 period.

Because the SEER database did not collect information on smoking demographics, the researchers said they subsequently sifted through a wide range of additional data covering 50 years of U.S. cigarette production and consumer habits in search of an underlying explanation.

Strauss and his colleagues said they found that the wide-scale adoption of filtered and low-tar cigarettes closely tracked the jump in adenocarcinoma rates.

Filtered cigarettes went from 1 percent of the U.S. market in 1950 to 64 percent by 1964. By 1986, filtered cigarettes had captured 95 percent of the market; by 2007 that figure was 98 percent.

"And while adenocarcinoma of the lung has always existed, it is now the most common form of lung cancer, and probably the second most common cause of cancer death," said Strauss. "Probably more people die specifically of smoking-related adenocarcinoma today than die of colon cancer."

"So while nothing is really new here, we're putting it all together," he said. And what emerges, he added, is the story of a tobacco industry that years back actively changed its product to minimize its known connection to certain types of cancers, thereby giving birth to a whole new carcinogenic threat and an even bigger lung cancer killer.

"And so now I'm hoping that there will be a recognition that the tobacco industry actually created this deadly epidemic of smoking-related adenocarcinoma through decades of deception," Strauss said.

The results of several other international studies were also presented this week at the South Korea conference, including a Norwegian finding that hand-rolled cigarettes are more carcinogenic than pre-packaged cigarettes, resulting in a higher risk for lung cancer.

Another study, out of Japan, showed that people with a family history of lung cancer
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Fresh Water Algae Filtered Out With Water Filtration Technique
2. Caffeine not really filtered out of decaf coffee
3. Use Filtered Blood for Transfusion: Expert
4. Air Pollution Stats Filtered in Ontario
5. Low-Tar Cigarettes As dangerous As High-Tar Cigarettes
6. Reducing Number Of Cigarettes Not Enough
7. Light Cigarettes - Not So Light?
8. British company developing ‘Safer Cigarettes
9. Nicotine patches instead of cigarettes – New Year resolutio
10. Genes May Determine Craving For Cigarettes
11. Safe Cigarettes Developed That Don’t Stain Your Teet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...h Annual Physician On-Call Pay .../ -- Sullivan, Cotter and Associates, Inc.,has pub...ll pay rates and,practices, the 2008 Physician On-...ta from 132 healthcare organizations nationwide, o...paid for 33 physician specialty areas along,with d...
(Date:7/25/2008)...lusivity Begins -, CORONA, Calif., July 25 /PRNew...NYSE: WPI ), a leading specialty pharmaceutical,c...mmenced commercial,shipment of its Omeprazole Dela...gth from its Davie, Florida manufacturing facility...ays of marketing exclusivity for being the,first t...
(Date:7/25/2008)...ert J. Reilly, Joins Aethon Team, PITTSBURGH, Jul...on.com ), the leading developer of mobile robotics...ced that Robert J. Reilly has,joined the company a...., Reilly, who was most recently Vice President -...alty Pharmacy Division, brings more than 30,years ...
(Date:7/25/2008)...ekta Family of Companies will,showcase their uniqu...merican Association of Physicists in Medicine (AAP...ces of Elekta, IMPAC and CMS are delivering,cuttin...utions that,streamline the treatment process to cr...enhance clinician efficiency., "Our recent acquis...
Breaking Medicine News(10 mins):Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3
...ther the reasons for swallowing the mobile phone b...or she purposely swallowed the mobile phone. // Th... in which it is said that the young lady purposely...th her boy friend in which she did not want to giv...
... two Israeli ophthalmologists Professor Michael Be...schleger Eye Institute at the Sheba Medical Centre...; They said that they have co-related all the prev...me out with strong evidences that obesity is the c...
...ave reported to have dead chicken and the cause th...ad chickens were tested and they showed positive r...placed an eastern town under scrutiny and have bee... of disease to other birds. The virus was first d...
...e polio eradication programme, initiated before 17...ent regions of the world. The programme was aimed ...of 2005. // The initiative, started in 1988, had a...adline has been set, and success may depend, in pa...
Other Medicine News:Health News:Increased Risk Of Losing Sight In Obese People. 2Health News:The Slow And Steady Race To Eradicate Polio Offers Hope 2
(Date:7/23/2008)...ing publication in July print edition of Clinical ... INDIANAPOLIS, July 23 /- A Roche Dia...of N-terminal pro-B-type natriuretic peptide,(NT-p...or risk,stratification in predicting the risk of c...reated with non-steroidal anti-inflammatory drugs ...
(Date:7/23/2008)...y 23 /- InCode BioPharmaceutics, Inc....ounced preclinical test,results demonstrating the ... treatment of the rare chronic blood disorder paro...e results will be presented at the XXII,Internatio...tember 28,2008., The only treatment currently av...
(Date:7/22/2008)...22 /- Nonin Medical, a leading innova... than 20 years, has entered,the clinical testing p...egional oxygen saturation. Today,s most common app...itoring of the regional blood oxygenation,in the b...d outcomes from an ongoing clinical study at the,D...
(Date:7/22/2008)...ing Lantus(R) and Apidra(R) Resulted in Significan...tes, Whatever the Algorithm ...wswire/ -- Results from the "Adjust to,Target in T...o Carbohydrate,Counting for Adjustment of Mealtime...merican Diabetes Association,s (ADA) medical journ...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 19147 1TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 19147 2TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 19147 3TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 19147 4TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 19147 5TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 19147 6TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 19147 7Psychology com Seeing Growing Acceptance of Online Therapy 19145 1Psychology com Seeing Growing Acceptance of Online Therapy 19145 2Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5337 1Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5337 2Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5337 3Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5337 4Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5337 5Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5337 6Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5337 7NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide Donating Agent in Hypertensive Patients by Merck 26 Co Inc 2046 1NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide Donating Agent in Hypertensive Patients by Merck 26 Co Inc 2046 2NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide Donating Agent in Hypertensive Patients by Merck 26 Co Inc 2046 3
...VERLY, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inot... presentation of,positive Phase 2 clinical data de...potential for INO-1001 as a preventative agent for...ed in subjects,with acute ST-elevated myocardial i...coronary intervention. The presentation was,made i...
...ETHESDA, Md., March 27, 2007--A new study shows th...e proportion of,cardiovascular disease (CVD) linke... emphasize the need for increased efforts to,preve...CVD risk,factors among those with diabetes, accord...amingham Heart Study, a program of the,National He...
Other Medicine Technology:Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years 2Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years 3
No Scalpel Vasectomy Ring Clamp, 5 1/2" (14cm), gold finger rings
Non-Cantilevered, "Teardrop" Ringed Forceps. ("fixation clamp") For vasectomy and other procedures. Ring ovoid approximately 6.0 mm in diameter.
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company.
...dule is an inconspicuous, lightweight, battery-ope...need to hear body functions amplified., ,The modu... integrated on/off switch, a tone switch, a stetho... The tone switch will allow the user to select bet...
Medicine Products: